Potassium uptitration and risk of atrial fibrillation - a prespecified analysis of the POTCAST randomised clinical trial

作者
C Zheng,U C G Winsloew,Elisabeth Margrethe Danielsen,T Sakthivel,K K Iversen,Helle Skovmand Bosselmann,Niels Risum,C Jons,H. Bundgaard
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:47 (Supplement_1)
标识
DOI:10.1093/eurheartj/ehag785.735
摘要

Abstract Background Hypokalaemia and low-normal plasma potassium levels are associated with increased risk of atrial fibrillation. This study examined if a potassium-increasing treatment strategy reduces the risk of clinically significant atrial fibrillation. Methods This is a prespecified analysis of the POTCAST trial; adults with an implantable cardioverter-defibrillator and plasma potassium level ≤4.3 mmol/L at baseline were randomised to a potassium-increasing treatment strategy consisting of dietary guidance on potassium rich foods combined with administration of a mineralocorticoid receptor antagonist, potassium supplements or both aimed at reaching high-normal plasma potassium levels (4.5-5.0 mmol/L) in addition to standard care (high-normal potassium group) or standard care alone (control group). The endpoint was a composite of acute hospitalisations due to atrial fibrillation leading to change of pharmacological treatment or due to inappropriate shock therapy, hospitalisation for electrical cardioversion or ablation of atrial fibrillation, and loading with amiodarone for atrial fibrillation in an out-patient setting or during an elective hospitalisation. The endpoint was evaluated in time-to-first-event analyses using the Fine-Gray subdistribution hazard model with death as competing risk. The cumulative incidence of clinically significant atrial fibrillation between randomisation groups was depicted using the Aalen-Johansen estimator account for death as a competing risk. Results Among 1200 participants (600 in each group, mean age 62.7±12.0 years, 80.3% male), 390 (32.5%) had a history of atrial fibrillation. Plasma potassium levels were increased by 0.3 mmol/L on average after uptitration in the high-normal potassium group compared to the control group. After a median follow-up of 3.3 person-years, the endpoint had occurred in 48 participants in the high-normal potassium group (8.0%, 2.80 events per 100 person-years), as compared with 73 participants in the control group (12.2%, 4.30 events per 100 person-years) (subdistribution hazard ratio, 0.65; 95% confidence interval, 0.45-0.93, P=0.02) (Figure 1). The treatment effect appeared similar across subgroups, including those with versus without a history of atrial fibrillation (Figure 2). Conclusion In adults with any cardiac disease, treated with an implantable cardioverter-defibrillator, uptitration of plasma-potassium levels targeting high-normal range significantly reduced the risk of clinically significant atrial fibrillation.Figure 1– Cumulative incidencesFigure 2- Subgroup analyses

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ZhQ完成签到,获得积分10
刚刚
刚刚
1秒前
小蘑菇的应助被沉默的晓旋采纳,获得10
1秒前
1秒前
mmmm发布了新的文献求助10
1秒前
wangguang完成签到,获得积分10
1秒前
miaomiaojiang发布了新的文献求助20
1秒前
YQ完成签到,获得积分10
1秒前
冬西燒发布了新的文献求助10
1秒前
loii举报wby的求助涉嫌违规
2秒前
我是谁的应助被Easily121采纳,获得30
2秒前
dove00完成签到,获得积分10
2秒前
2秒前
小席要进步完成签到 ,获得积分10
2秒前
2秒前
主任发布了新的文献求助10
2秒前
3秒前
张大帅完成签到,获得积分10
3秒前
3秒前
小周的读研日常完成签到,获得积分10
3秒前
3秒前
柳絮完成签到,获得积分10
3秒前
3秒前
星辰大海的应助被端庄沉鱼采纳,获得10
3秒前
SWZ发布了新的文献求助10
3秒前
4秒前
禾禾完成签到,获得积分10
4秒前
5秒前
5秒前
btyyl完成签到,获得积分10
5秒前
沾沾发布了新的文献求助10
6秒前
激情的钢笔完成签到,获得积分10
6秒前
Dr.ming完成签到,获得积分20
6秒前
6秒前
6秒前
俏皮的奎发布了新的文献求助10
7秒前
YU完成签到,获得积分10
7秒前
认真的冬易完成签到 ,获得积分10
7秒前
chloe完成签到,获得积分0
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160095
求助须知:如何正确求助?哪些是违规求助? 9555300
关于积分的说明 21726769
捐赠科研通 7749888
什么是DOI,文献DOI怎么找? 3427335
关于科研通互助平台的介绍 2552391
邀请新用户注册赠送积分活动 2471673